KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Ionis Pharmaceuticals (IONS) over the last 17 years, with Q3 2025 value amounting to $41.1 million.

  • Ionis Pharmaceuticals' Net Cash Flow rose 212.86% to $41.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 million, marking a year-over-year increase of 11931.88%. This contributed to the annual value of -$156.9 million for FY2024, which is 22815.54% down from last year.
  • As of Q3 2025, Ionis Pharmaceuticals' Net Cash Flow stood at $41.1 million, which was up 212.86% from $32.5 million recorded in Q2 2025.
  • In the past 5 years, Ionis Pharmaceuticals' Net Cash Flow registered a high of $236.3 million during Q4 2021, and its lowest value of -$326.5 million during Q1 2022.
  • Over the past 5 years, Ionis Pharmaceuticals' median Net Cash Flow value was $21.9 million (recorded in 2025), while the average stood at -$3.1 million.
  • Per our database at Business Quant, Ionis Pharmaceuticals' Net Cash Flow plummeted by 206499.97% in 2022 and then soared by 67314.34% in 2023.
  • Over the past 5 years, Ionis Pharmaceuticals' Net Cash Flow (Quarter) stood at $236.3 million in 2021, then plummeted by 116.53% to -$39.1 million in 2022, then soared by 219.99% to $46.9 million in 2023, then tumbled by 296.35% to -$92.0 million in 2024, then surged by 144.67% to $41.1 million in 2025.
  • Its Net Cash Flow was $41.1 million in Q3 2025, compared to $32.5 million in Q2 2025 and $21.9 million in Q1 2025.